2020-04-22 08:16:00 GCP GCP Applied Technologies
04/22/20 04/2208:16 04/22/2008:16 | GCP Applied Technologies urges shareholders to vote for director nomineesGCP Applied Technologies issued the following open letter to shareholders in connection with GCP's 2020 Annual Meeting of Stockholders, urging them to Vote "FOR" ALL Its Director Nominees on the BLUE Proxy Card: The company said, "Amid the significant uncertainty and volatility caused by the COVID-19 pandemic, the GCP Board and management team have been working with relentless focus to execute our operating plan and deliver value for shareholders while prioritizing the safety of employees and customers. Despite our substantial and continued progress, Starboard has insisted on moving forward with an unnecessary and unjustified proxy fight to appoint a supermajority of GCP's Board. We urge you to consider the results our recently refreshed Board has delivered, the proactive steps we have taken to position the Company for long-term success and the undue disruption to GCP's progress and momentum that could result from replacing nearly all directors on the Board. We recommend that shareholders vote the BLUE proxy card or voting instruction form to support GCP's highly qualified board of directors...Our team continues to drive significantly improved performance. We have previously outlined the many initiatives implemented to enhance operational performance and create value. On April 15, we demonstrated our continued progress against this plan when we provided expected financial results for the first quarter of 2020 that significantly exceeded consensus estimates and would represent our best first quarter earnings performance since 2016. Highlights of our expected results include sales growth in North America from both Specialty Construction Chemicals and Specialty Building Materials, growth in expected Adjusted EBIT of approximately 17% year-over-year to approximately $14 million, and expected Adjusted EBIT Margin expansion to approximately 6.5% in the first quarter of 2020 compared to 5.3% in the first quarter of 2019. We also expect first quarter Adjusted EPS growth of approximately 29% year-over-year to $0.09. Our progress and expected results in the first quarter of 2020 further advance the successes we have delivered under the leadership of our CEO Randy Dearth over the past year...Importantly, our Board and management team have also maintained a disciplined approach to capital management that has resulted in a very strong balance sheet with significant liquidity and no near-term debt maturities. Today, our balance sheet is a competitive differentiator, providing substantial financial flexibility and positioning us to successfully manage through the ongoing economic challenges and uncertainty caused by the COVID-19 pandemic...The GCP Board has demonstrated a longstanding commitment to regular, disciplined refreshment. This year, we nominated two new independent directors - Armand F. Lauzon, Jr. and John R. McPherson - to enhance our Board and help drive GCP's continued progress. We are confident that the Board and our 2020 nominees possess the expertise, operational and industry experience, knowledge, and skills to support the continued execution of GCP's strategy...GCP's recently refreshed Board is also delivering significant performance improvement and positive business results. While Starboard has not presented substantive alternative ideas to enhance value at GCP after over a year of engagement with the Company, the GCP Board has overseen the successful execution of the Company's strategic initiatives to improve business fundamentals and position GCP for long-term value creation. We look forward to the opportunity to further advance our current momentum...At GCP's upcoming Annual Meeting on May 28, 2020, shareholders will be asked to make an important decision regarding the composition of the Company's Board and its path for the future, which we believe will have an impact on your investment in the Company. We believe that Starboard's attempt to replace nearly all of the Company's directors would create unnecessary risk for your investment and the value creation trajectory the current Board and leadership team have demonstrated they are capable of delivering. The Company's top focus and priority needs to be on continuing to execute in a challenging and rapidly evolving operating environment to drive value for our shareholders, while also ensuring the safety, health and wellbeing of our employees, customers and business partners. We remain firm in our belief that the Company's director nominees are best suited to lead GCP and deliver value." |
|
---|---|---|
|
On The Fly
|
Opening Day: InnovAge rises, Oscar Health slips on first trading day »
09:14 03/07/21 03/0709:14 03/07/2109:14
INNV
InnovAge
Oscar Health
VPC Impact Acquisition Holdings III
VPC Impact Acquisition Holdings II
Warburg Pincus Capital Corporation I-A
Tribe Capital Growth Corp I
Warburg Pincus Capital Corporation I-B
dMY Technology Group IV
Tailwind Two Acquisition
First Reserve Sustainable Growth
InterPrivate IV InfraTech Partners
InterPrivate III Financial Partners
InterPrivate II Acquisition
Property Solutions Acquisition II
Khosla Ventures Acquisition
Aurora Acquisition
Altimar Acquisition Corp. III
Twin Ridge Capital Acquisition
Isos Acquisition
Mission Advancement
Roth CH Acquisition III
DHB Capital
Goldenbridge Acquisition
TCW Special Purpose Acquisition
FinTech Evolution Acquisition
Supernova Partners Acquisition II
Orion Acquisition
NightDragon Acquisition
Anzu Special Acquisition Corp I
Northern Star Investment Corp. IV
Northern Star Investment Corp. III
Live Oak Mobility Acquisition
Advanced Merger Partners
Coinbase
Roblox
Vizio
Gold Royalty
Alignment Healthcare
Robinhood
Palantir
Asana
Slack Technologies
Spotify
Alibaba
Elder-care company… ShowHide Related Items >><<
|
Conference/Events
|
Super Micro Computer participates in a conference call with Northland »
16:53 03/06/21 03/0616:53 03/06/2116:53
SMCI
Super Micro Computer
Conference call with CFO… Conference call with CFO Weigand will be held on March 12 at 12 pm. Webcast Link ShowHide Related Items >><<
|
Conference/Events
|
Accuray participates in a conference call with Northland »
16:51 03/06/21 03/0616:51 03/06/2116:51
ARAY
Accuray
Cconference call with… Cconference call with President & CEO Levine and CCO Winter will be held on March 15 at 12 pm. Webcast Link ShowHide Related Items >><<
|
Periodicals
|
Cisco, Qualcomm offer solid yield, dividend growth, Barron's says »
12:36 03/06/21 03/0612:36 03/06/2112:36
AVGO
Broadcom
Cisco
Qualcomm
Texas Instruments
It's hard to find… It's hard to find attractive yields with dividend growth among tech stock but Broadcom (AVGO), Cisco (CSCO), Qualcomm (QCOM) and Texas Instruments (TXN) offer both, Lawrence Strauss writes on this week's edition of Barron's. Reference Link ShowHide Related Items >><<
|
Periodicals
|
Vertex underperformance after drug setback a buying opportunity, Barron's says »
12:19 03/06/21 03/0612:19 03/06/2112:19
VRTX
Vertex Pharmaceuticals
For nearly a decade,… For nearly a decade, Vertex Pharmaceuticals could do no wrong but then the biotech company canceled development of a once-promising drug after trial results disappointed and its stock is now down 25% since mid-October, Josh Nathan-Kazis writes in this week's edition of Barron's. The pullback has been overdone, the author contends, adding that there is an opportunity now for investors to get back in. Reference Link ShowHide Related Items >><<
|
Periodicals
|
Lowe's can win reopening, stock a buy, Barron's says »
12:12 03/06/21 03/0612:12 03/06/2112:12
LOW
Lowe's
Lowe's was a… Lowe's was a lockdown winner and investors are having second thoughts about its stock now that reopening looms, but Lowe's is far more than just a COVID-19 play, Teresa Rivas writes in this week's edition of Barron's. Concerns are probably overblown and with COVID receding, Lowe's is set to become a more profitable company, while housing might be more resilient than it's given credit for, the author contends. Reference Link ShowHide Related Items >><<
|
Periodicals
|
MyTheresa stock might be cheapest thing it sells, Barron's says »
12:01 03/06/21 03/0612:01 03/06/2112:01
MYTE
Mytheresa
Mytheresa stock -… Mytheresa stock - technically an American depositary share of parent company MYT Netherlands Parent - was recently trading just below its $26 initial-public-offering price after having jumped to $36 shortly after the debut, Nicholas Jasinski writes in this week's edition of Barron's. The stock could recover those losses and more in the coming months, the author contends, noting that while luxury buyer might have been slower to adopt e-commerce, the overall luxury market is growing by about 7% annually. Reference Link ShowHide Related Items >><<
|
Initiation
|
Cloopen initiated with a Neutral at Goldman Sachs »
09:57 03/06/21 03/0609:57 03/06/2109:57
RAAS
Cloopen
Goldman Sachs analyst… Goldman Sachs analyst Tina Hou initiated coverage of Cloopen Group Holding with a Neutral rating and $16.20 price target, implying 9% downside. Cloopen is China's largest multi-capability cloud-based communications solution provider by revenues with with 12,000 active customers as of Q3, Hou tells investors in a research note. The analyst likes Cloopen's "ample" market opportunities and "comprehensive" product offering, but believes current valuations already reflect the stock's long-term growth potential. ShowHide Related Items >><<
|
Initiation
|
Adagene initiated with a Buy at Goldman Sachs »
09:55 03/06/21 03/0609:55 03/06/2109:55
ADAG
Adagene
Goldman Sachs analyst… Goldman Sachs analyst Ziyi Chen initiated coverage of Adagene with a Buy rating and $29 price target, which represents 26% upside. Adagene is a pre-revenue biotech company with a proprietary antibody drug discovery platform, Chen tells investors in a research note. The analyst believes Adagene has the potential to "revolutionize antibody drug discovery" if its dynamic precision library platform is fully validated. Chen sees "multiple value-driving catalysts" in 2021. ShowHide Related Items >><<
|
On The Fly
|
Charged: GM-backed Cruise said to be in talks to acquire Voyage »
07:31 03/06/21 03/0607:31 03/06/2107:31
TSLA
Tesla
NIO
Xpeng
Ford
Li Auto
General Motors
Fisker
QuantumScape
Plug Power
NextEra Energy
Welcome to The Fly's… ShowHide Related Items >><<
|
General news
| Treasury Market Summary:… Treasury Market Summary: nonfarm payrolls bolted 379k higher and the blowout jobs report made for some big swings in the markets before both bonds and stocks settled into gains in late day trading. The markets were volatile but not disorderly and the relative calm was beneficial in general. Treasury yields shot higher with longer dated maturities breaching the February 25 intraday highs to post the cheapest rates in over a year. The wi 10-year rose over 6 bps to test 1.624% before slipping back to 1.57% at the close. The wi 30-year bond was 2 bps lower at 2.305%, and the 2-year was down 0.8 bps to 0.137%. Wall Street was knocked lower again in reaction to the rise in rates, as has been the recent trend. The S&P 500 dropped -1% to hit 3730 before dip buying emerged, supported by a "good news is good news" trade. All of the indexes climbed through the afternoon with the S&P 500 leading the rally, finishing 1.95% firmer at 3841 to boost the index 1% higher to 3823. The Dow rose 1.85% to 31,496. And after lagging much of the session, the NASDAQ closed up 1.55% to 12,920. View the summary. |
Hot Stocks
|
Ellington Financial reports estimated book value per share of $18.06 on Feb 28 »
19:00 03/05/21 03/0519:00 03/05/2119:00
EFC
Ellington Financial
The company announced its… The company announced its estimated book value per common share of $18.06 as of February 28. This estimate includes the effect of the previously announced monthly dividend of 10c per common share, payable on March 25 to holders of record on February 26, with an ex-dividend date of February 25. ShowHide Related Items >><<
|
Hot Stocks
|
Adaptive Biotechnologies says FDA issues EUA for T-Detect COVID »
18:47 03/05/21 03/0518:47 03/05/2118:47
ADPT
Adaptive Biotechnologies
Microsoft
Adaptive Biotechnologies… Adaptive Biotechnologies (ADPT) announced that the U.S. FDA issued an Emergency Use Authorization for T-Detect COVID to confirm recent or prior COVID-19 infection. This first-in-class T cell- based test is the first indication resulting from Adaptive's TCR-Antigen Map collaboration with Microsoft (MSFT). ShowHide Related Items >><<
|
Hot Stocks
|
Okta CEO: Really excited about the execution of the company »
18:28 03/05/21 03/0518:28 03/05/2118:28
OKTA
Okta
SolarWinds
In an interview on… In an interview on CNBC's Mad Money, Todd McKinnon said Okta's (OKTA) combination with Auth0 gives customers great choice and flexibility. "It's not a small company, it's scaling," he said. "If you look at the SolarWinds (SWI) incident, it's clear that everything in the office must be secure," he added. ShowHide Related Items >><<
|
Periodicals
|
California to allow theme parks, sports stadiums to reopen soon, L.A. Times says »
18:02 03/05/21 03/0518:02 03/05/2118:02
DIS
Disney
Cedar Fair
SeaWorld
Six Flags
The state of California… The state of California will allow theme parks and sports stadiums in the state to welcome back visitors sooner than expected under new guidance unveiled Friday, the Los Angeles Times' Luke Money and Rong-Gong Lin II report. While the changes don't mean such facilities can operate at full capacity right away, they do reflect the state's growing sentiment that it is now possible to resume certain activities as COVID-19 case rates decline and as the vaccine rollout continues to ramp up, the authors note. Beginning April 1, amusement parks in California will be eligible to reopen with limited capacity in counties that are in the red tier, also known as the second-strictest of the state's four-category reopening roadmap, the authors say. Companies that operate theme parks in California include Disney (DIS), Cedar Fair (FUN), SeaWorld (SEAS), and Six Flags (SIX). Reference Link ShowHide Related Items >><<
|
Hot Stocks
|
SPDR Gold Shares holdings fall to 1,069.26MT from 1,078.30MT »
17:54 03/05/21 03/0517:54 03/05/2117:54
GLD
SPDR Gold Shares
This is the 3rd… This is the 3rd consecutive decrease in holdings and the lowest level since May 1st, 2020. ShowHide Related Items >><<
|
Hot Stocks
|
First Solar's Hambro sells 10,000 common shares »
17:50 03/05/21 03/0517:50 03/05/2117:50
FSLR
First Solar
In a regulatory filing,… In a regulatory filing, First Solar director George A. Hambro disclosed the sale of 10,000 common shares of the company on March 3 at a price of $80.67 per share. ShowHide Related Items >><<
|
Hot Stocks
|
CytoDyn says Phase 3 leronlimab trial demonstrates survival rate improvement »
17:49 03/05/21 03/0517:49 03/05/2117:49
CYDY
CytoDyn
CytoDyn reported the… CytoDyn reported the Phase 3 trial of leronlimab for the treatment of severe-to-critical patients with COVID-19 demonstrated continued safety, substantial improvement in the survival rate, and faster hospital discharge in critically ill COVID-19 patients. The trial's data has been reported to the U.S. Food and Drug Administration, the U.K.'s Medicines & Healthcare product Regulatory Agency and Health Canada, and the company is in discussions with each to determine the best path forward for approval of leronlimab for treatment of COVID-19 in critically ill population. A manuscript of the trial's data is being prepared and will be submitted for publication in one or more major medical journals. Scott A. Kelly, M.D., Chairman and Chief Medical Officer, noted, "We believe this further supports CCR5 as a therapeutic target for immunomodulation and the importance of the disruption of the CCL5-CCR5 axis via leronlimab-mediated CCR5 blockade of pro-inflammatory leukocytes and reversal of the cytokine storm in critical COVID-19 patients." ShowHide Related Items >><<
|
Periodicals
|
Standard General invigorates push for Tegna board seats, Bloomberg reports »
17:47 03/05/21 03/0517:47 03/05/2117:47
TGNA
Tegna
Standard General LP,… Standard General LP, which owns a 9.2% interest in Tegna, is ramping up its push for board seats at the company a year after investors spurned its call for change as the COVID-19 pandemic took hold, Bloomberg's Scott Deveau reports. Standard General CEO Soo Kim told Bloomberg in an interview that his slate of nominees would bring ample industry experience and diverse points of view to Tegna's board. Kim claims that Tegna has benefited from the firm's activism even without the firm having representation on the board, Deveau notes. Reference Link ShowHide Related Items >><<
|
Hot Stocks
|
Freeport McMoRan's Ford sells 300,000 common shares »
17:38 03/05/21 03/0517:38 03/05/2117:38
FCX
Freeport McMoRan
In a regulatory filing,… In a regulatory filing, Freeport McMoRan director Gerald J. Ford disclosed the sale of 300,000 common shares of the company on March 4 at a price of $33.2359 per share. ShowHide Related Items >><<
|
Periodicals
|
Most Senate Dems agree to lower jobless benefits to $300 per week, WSJ says »
17:37 03/05/21 03/0517:37 03/05/2117:37
SPX
S&P 500
SPDR S&P 500 ETF Trust
Most Senate Democrats… Most Senate Democrats agreed to cut weekly federal unemployment benefits to $300 a week from the $400 passed by the House as part of a $1.9T COVID-19 relief bill, the Wall Street Journal's Kristina Peterson, Andrew Duehren, and Richard Rubin report. Most Democratic senators agreed to cut the benefits but extend them through October 4 instead of August 29, the authors say, noting that Democrats also proposed making the first $10,200 of the 2020 benefits nontaxable. Reference Link ShowHide Related Items >><<
|
Hot Stocks
|
Luokung Technology gets suspension of trading notice from Nasdaq »
17:32 03/05/21 03/0517:32 03/05/2117:32
LKCO
Luokung Technology
Luokung Technology… Luokung Technology announced that the company received a notice from Nasdaq informing the Company that as a result of the company being placed by the U.S. Department of Defense list of "Communist Chinese Military Companies" operating directly or indirectly in the United States, which are subject to certain restrictions under Executive Order 13959, that trading of the company's ordinary shares will be suspended at the opening of business on March 15, 2021. Nasdaq will file a Form 25-NSE with the SEC, which will remove the company's securities from listing and registration on The Nasdaq Stock Market. The company plans to appeal the Nasdaq Staff's determination to a Hearings Panel. ShowHide Related Items >><<
|
Syndicate
|
Passage Bio files to sell $125M of common stock »
17:25 03/05/21 03/0517:25 03/05/2117:25
PASG
Passage Bio
Cowen and Company is… Cowen and Company is managing the offering. ShowHide Related Items >><<
|
Syndicate
|
Coursera files registration statement for initial public offering »
17:25 03/05/21 03/0517:25 03/05/2117:25
COUR
Coursera
Coursera announced that… Coursera announced that it has publicly filed a registration statement on Form S-1 with the SEC relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Coursera has applied to list its common stock on the New York Stock Exchange under the ticker symbol "COUR". Morgan Stanley and Goldman Sachs will act as lead book-running managers for the proposed offering. Citigroup and UBS Investment Bank will act as additional bookrunners, and KeyBanc Capital Markets, Raymond James, Stifel, Truist Securities, William Blair, D.A. Davidson & Co., Needham & Company, Loop Capital Markets, and Telsey Advisory Group will act as co-managers for the proposed offering. |
Syndicate
|
Passage Bio files automatic mixed securities shelf
17:24 03/05/21 03/0517:24 03/05/2117:24
PASG
Passage Bio
ShowHide Related Items >><<
|